An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The main purpose of this study is to determine if applying mupirocin into soldiers noses who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) will reduce infections in them and their cohort of fellow soldiers.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Brooke Army Medical Center
• Collaborators: Becton, Dickinson and Company; GlaxoSmithKline
• Treatments: Methicillin; Mupirocin

Criteria

Inclusion Criteria:Soldiers enrolled into the combat medic course at Ft. Sam Houston, TX.

-

Exclusion Criteria: Allergy to mupirocin.

-